Back to timeline
Verified
Records

CDC MMWR: during Delta, prior infection protected more than vaccination alone; hybrid protection highest

CDC and the California and New York health departments published an MMWR analysis of statewide case, hospitalization, and immunization data from May–November 2021 across four adult cohorts. Before Delta became predominant (June–July 2021), case rates were lowest among vaccinated people without a prior diagnosis; by the week of October 3, case rates were substantially lower in both cohorts with prior infection, and lowest among people with both vaccination and prior infection, while unvaccinated people without a prior diagnosis always had the highest case and hospitalization rates. In an accompanying statement, CDC stressed the analysis predated Omicron and widespread boosters, did not account for the risks of the initial infection, and maintained that vaccination remains the safest strategy.

Primary quotes

Other
Vaccination remains the safest strategy for protecting against COVID-19.

CDC media statement on the MMWR, January 20, 2022

Other
infection-derived protection was higher after the Delta variant became predominant, a time when vaccine-induced immunity for many persons declined because of immune evasion and immunologic waning

León et al., MMWR 71(4):125–131

Linked sources

COVID-19 Cases and Hospitalizations by Vaccination Status and Previous Diagnosis — California and New York, May–Nov. 2021 (MMWR 71(4))
Tier 1 · report · León et al.; Early Release Jan. 19, 2022
New CDC studies add to evidence of benefits of COVID-19 vaccination (CDC archive statement)
Tier 1 · other · Jan. 20, 2022 caveats: pre-Omicron, pre-booster, no data on severity of initial infection
Natural immunity was more potent than vaccines during US Delta wave — study (Times of Israel)
Tier 3 · news · Contemporaneous coverage of the MMWR shift and hybrid-protection finding

Related contentions

Official handling of infection-acquired ('natural') immunity

The timeline of what officials said and when is well documented; the dispute is over interpretation — whether the gap between emerging evidence and official acknowledgment reflected scientific caution or messaging discipline. No official review has adjudicated the claim, and the question remains contested.